Filing Details
- Accession Number:
- 0001061983-22-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-06 19:12:26
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-06 19:12:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1710875 | Ching Jaw | 350 Oyster Point Blvd South San Francisco CA 94080 | Svp Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-04 | 15,000 | $12.10 | 82,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-04 | 15,000 | $40.00 | 67,109 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-05 | 10,000 | $12.10 | 77,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-05 | 10,000 | $42.00 | 67,109 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-04 | 15,000 | $0.00 | 15,000 | $12.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-05 | 10,000 | $0.00 | 10,000 | $12.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,944 | 2018-06-30 | 2027-06-30 | No | 4 | M | Direct |
| 1,944 | 2018-06-30 | 2027-06-30 | No | 4 | M | Direct |
Footnotes
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
Billionaire Hedge Funds
